Abstract
Many bacteria can be detected in CF sputum, pathogenic and commensal. Modified Koch’s criteria for identification of established and emerging CF pathogens are therefore described. Methods are described to isolate bacteria and to detect bacterial biofilms in sputum or lung tissue from CF patients by means of conventional culturing and staining techniques and by the PNA FISH technique. Additionally, the confocal scanning laser microscopy technique is described for studying biofilms in vitro in a flow cell system. The recA-gene PCR and the RFLP-based identification methods are described for identification of isolates from the Burkholderia complex to the species level. DNA typing by PFGE, which can be used for any bacterial pathogen, is described as it is employed for Pseudomonas aeruginosa. A commercially available ELISA method is described for measuring IgG antibodies against P. aeruginosa in CF patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Westh, J. B. (2001) Pulmonary Physiology and Pathophysiology. Lippincott Williams & Wilkins, Philadelphia, PA.
Boucher, R. C. (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23, 146–158.
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., et al. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44, 547–558.
Høiby, N., and Frederiksen, B. (2000) Microbiology of cystic fibrosis, in (Hodson, M. E., and Geddes, D. M., eds.), Cystic Fibrosis, 9th ed. Arnold, London, pp. 83–107.
Wilson, M. (2005) Microbial Inhabitants of Humans. Cambridge, Cambridge University Press.
Høiby, N., and Pressler, T. (2006) Emerging pathogens in cystic fibrosis. Eur Respir Monog Cyst Fibros Eur Respir Soc 35, 66–78.
Skov, M., Koch, C., Reimert, C. M., and Poulsen, L. K. (2000) Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Allergy 55, 50–58.
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., et al. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109, 317–325.
Kolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., et al. (2010) Polymorphonuclear leukocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65, 57–62.
Worlitzsch, D., Rintelen, C., Bohm, K., Wollschlager, B., Merkel, N., Borneff-Lipp, M., et al. (2009) Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect 15, 454–460.
Koch, R. (1884) Die Aetiologie der Tuberkulose. Mittheil Kaiserl Gesundheitsamt 2, 1–88.
Taylor-Robinson, D. (1983) The role of M. genitalum in non-gonococcal urethritis: a review. Yale J Biol Med 56, 537–543.
Høiby, N. (1974) Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B 82, 541–550.
Lee, T.W.R., Brownlee, K.G., Conway, S.P., Denton, M., and Littlewood, J.M. (2003) Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2, 29–34.
Proesmans, M., Balinska-Miskiewicz, W., Dupont, L., Bossuyt, X., Verhaegen, J., Høiby, N., et al. (2006) Evaluating the “Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis center. Eur Respir J 27, 937–943.
Pressler, T., Karpati, F., Gramström, M., Knudsen, P.K., Lindblad, A., Hjelte, L., et al. (2009) Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 8, 37–42.
Döring, G., Buhl, V., Høiby, N., Schiøtz, P. O., and Botzenhart, K. (1984) Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients. Acta Pathol Microbiol Scand C 92, 307–312.
Høiby, N. (2002) Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J Cyst Fibros 1, 249–254.
Wainwright, C. E., Grimwood, K., Carlin, J. B., Vidmar, S., Cooper, P. J., Francis, P.W., et al. (2008) Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatr Pulmonol 43, 965–972.
Murray, P. R., Baron, E. J., Jorgensen, J. H., Landry, M. L., and Pfaller, M. A. (2007) Manual of Clinical Microbiology, 9th ed. ASM Press, Washington DC.
Diederen, B. M. W., van Leest, M. -L., van Duijin, I., Willemse, P., van Keulen, P. H. J., and Kluytmans, J. A. J. W. (2006) Performance of MRSA ID, a new chromogenic medium for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 44, 586–588.
Levi, K., and Towner, K. J. (2003) Detection of methicillin-resistant Staphylococcus aureus (MRSA) in blood with the EVIGENE MRSA detection kit. J Clin Microbiol 41, 3890–3892.
Hoffmann, N., Rasmussen, T. B., Jensen, P. Ø., Stub, C., Hentzer, M., Molin, S., et al. (2005) Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun 73, 2504–2514.
Haussler, S., Ziegler, I., Lottel, A., von Gotz, F., Rohde, M., Wehmhohner, D., et al. (2003) Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol 52, 295–301.
Balke, B., Schmoldt, S., Haussler, S., Suerbaum, S., Heesemann, J., and Hogardt, M. (2008) A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis. J Cyst Fibros 7, 7–14.
Coenye, T., Vandamme, P., Govan, J. R. W., and Lipuma, J. J. (2001) Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39, 3427–3436.
Degand, N., Carbonelle, E., Dauphin, B., Beretti, J. -L., Bourgeois, M. L., Sermet.Gaudelus, I., et al. (2008) Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 46, 3361–3367.
Wellinghausen, N., Kothe, J., Wirths, B., Sigge, A., and Popperts, S. (2005) Superiority of molecular techniques for identification of Gram-negative, oxidase-positive rods, including morphological nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 43, 4070–4075.
Fluge, G., Ojeniyi, B., Høiby, N., Digranes, A., Ciofu, O., Hunstad, E., et al. (2001) Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin Microbiol Infect 7, 238–243.
Yang, L., Haagensen, J. A. J., Jelsbak, L., Johansen, H. K., Sternberg, C., Høiby, N., et al. (2008) In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infection. J Bact 190, 2767–2776.
Xu, J., Moore, J. E., Murphy, P. G., Millar, B. C., Redmond, A. O. B., and Elborn, J. S. (2004) Molecular (PCR) detection of Pseudomonas spp. other than P-aeruginosa directly from the sputum of adults and children with cystic fibrosis. Br J Biomed Sci 61, 147–149.
Høiby, N. (1977) Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Path Microbiol Scand Suppl 262 C, 3–96.
Bjarnsholt, T., Kirketerp-Møller, K., Jensen, P. Ø., Madsen, K. G., Phipps, R., Krogfelt, K., et al. (2008) Why chronic wounds won’t heal: a novel hypothesis. Wound Rep Regen 16, 2–10.
Bjarnsholt, T., Tolker-Nielsen, T., Givskov, M., Janssen, M., and Christensen, L. H. (2009) Detection of bacteria by FISH in culture-negative soft tissue filler lesions. Dermatol Surg 35, 1620–1624.
Høiby, N., Johansen, H. K., Moser, C., Song, Z. J., Ciofu, O., and Kharazmi, A. (2001) Pseudomonas aeruginosa and the biofilm mode of growth. Microb Infect 3, 1–13.
Donlan, R. M., and Costerton, J. W. (2002) Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167–178.
Bjarnsholt, T., Jensen, P. Ø., Burmølle, M., Hentzer, M., Haagensen, J. A. J., Hougen, H. P., et al. (2005) Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151, 373–383.
Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., and Stewart, P. S. (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47, 317–323.
O’Toole, G., Kaplan, H. B., and Kolter, R. (2000) Biofilm formation as microbial development. Ann Rev Microbiol 54, 49–79.
Sauer, K. T. (2003) The genomics and proteomics of biofilm formation. Genome Biol 4, 219–229.
Hentzer, M., Eberl, L., and Givskov, M. (2005) Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2, 37–61.
Purevdorj, B., Costerton, J. W., and Stoodley, P. (2002) Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appl Env Microbiol 68, 4457–4464.
Reimmann, C., Ginet, N., Michel, L., Keel, C., Michaux, P., Krishnapillai, V., et al. (2002) Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1. Microbiology 148, 923–932.
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., and Davies, D. G. (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bact 184, 1140–1154.
Klausen, M., Aaes-Jorgensen, A., Molin, S., and TolkerNielsen, T. (2003) Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol 50, 61–68.
Hansen, C. R., Pressler, T., Nielsen, K. G., Jensen, P. Ø., Bjarnsholt, T., and Høiby, N. (2010) Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 9, 51–58.
Christensen, B. B., Sternberg, C., Andersen, J. B., Palmer, R. J., Nielsen, A. T., Givskov, M., et al. (1999) Molecular tools for study of biofilm physiology. Biofilms 1, 20–42.
Coenye, T., Mahenthiralingam, E., Henry, D., LiPuma, J. J., Laevens, S., Gillis, M., et al. (2001) Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol 51, 1481–1490.
Mahenthiralingam, E., Bischof, J., Byrne, S. K., Radomski, C., Davies, J. E., AvGay, Y., et al. (2000) DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38, 3165–3173.
Romling, U., and Tümmler, B. (2000) Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol 38, 464–465.
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis. Criteria for bacterial strains typing. J Clin Microbiol 33, 2233–2239.
Struelens, M. J. (1996) Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect 2, 2–11.
Pressler, T., Frederiksen, B., Skov, M., Garred, P., Koch, C., and Høiby, N. (2006) Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection – a case control study. J Cyst Fibros 5, 9–15.
Ratjen, F., Walter, H., Haug, M., Meisner, C., Grasemann, H., and Döring, G. (2007) Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol 42, 249–255.
Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., and Høiby, N. (2008) Spread of colistin-resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 7, 391–397.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bjarnsholt, T., Nielsen, X.C., Johansen, U., Nørgaard, L., Høiby, N. (2011). Methods to Classify Bacterial Pathogens in Cystic Fibrosis. In: Amaral, M., Kunzelmann, K. (eds) Cystic Fibrosis. Methods in Molecular Biology, vol 742. Humana Press. https://doi.org/10.1007/978-1-61779-120-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-61779-120-8_9
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-119-2
Online ISBN: 978-1-61779-120-8
eBook Packages: Springer Protocols